SCHEMBL5069892

SCHEMBL5069892

C[C](C(C)(C)C)C(C)(C)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4620261 0.72
SCHEMBL1983798 0.69
SCHEMBL8751405 0.67
SCHEMBL27914908 0.67
SCHEMBL19268410 0.67 ALDH1A1 (0.32) ALDH1A1CYP2C19
SCHEMBL7142735 0.67
SCHEMBL803622 0.67
SCHEMBL11035638 0.65 ALDH1A1 (0.30) ALDH1A1CYP2C19
SCHEMBL10819165 0.65 ALDH1A1 (0.30) ALDH1A1CYP2C19
SCHEMBL29249382 0.65 ALDH1A1 (0.37) ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545923-A1 Antibacterial agents Alchemia Limited (AU) 2013-01-16 EP disclosed
EP-1934388-B1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2012-12-05 EP disclosed
EP-1934388-A1 METHOD OF DRUG DESIGN Alchemia Ltd (AU) 2008-06-25 EP disclosed
WO-2007038829-A1 METHOD OF DRUG DESIGN ALCHEMIA LTD (AU) 2007-04-12 WO disclosed